Key Takeaways from CDDF Live Webinar Series – “AI and Big Data AI in Drug Development: Use of AI in Clinical Trials” (12 May 2026)
The CDDF is pleased to share the key takeaways from our live webinar series – “AI and Big Data AI in Drug Development: Use of AI in clinical trials” held on 12 May 2026. This webinar included a lecture by Dr. James Gulley (NIH) followed by a 30-minute Q&A...![[ACT EU Workplan for 2026-2027 – Version 4, May 2026]](https://cddf.org/wp-content/uploads/2026/05/Capture-1080x675.jpg)
[ACT EU Workplan for 2026-2027 – Version 4, May 2026]
The ACT EU workplan for 2026 – 2027 has been adopted by the ACT EU Steering Group and is now published. The workplan reflects the revised ACT EU objectives and takes into account recent legislative and policy developments including the proposed Biotech Act, the...
Executive Summary: CDDF & AAADV Workshop – Challenges in the Landscape of a Global Development Strategy Including Patient Access (30-31 March 2026, BE)
The Cancer Drug Development Forum (CDDF) is delighted to announce that the executive summary of the CDDF & AAADV joint workshop on “Challenges in the Landscape of a Global Development Strategy Including Patient Access” has been published today. This...![[News from ACT EU] – Clinical Trials Information System (CTIS): training and support](https://cddf.org/wp-content/uploads/2026/04/Copy-of-PUBLICATION-Annual-Repport-2024-Is-available-4-1080x675.jpg)